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have been synthesized and their antimicrobial activity as well as a comparison study between con-
ventional and microwave techniques has been done. Antimicrobial activity was carried out accord-
ing to the broth micro dilution method and it was observed that compound 2d was found to be most
active against gram negative bacteria and fungus Candida albicans. Microwave technique has been
found superior over the conventional method in view of reaction time and energy requirement.
Compounds have been characterized by 1H NMR, 13C NMR, IR and Mass spectral analyses.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Synthesis from microwave irradiation was ﬁrst carried out in
1986 (Gedye et al., 1986). This pioneer work ignited the scope
of microwave assisted synthesis. A number of articles werepublished on the microwave assisted synthesis and its compar-
ison with conventional methods. This revealed that the micro-
wave irradiated synthesis proved to be superior to that of
conventional ones in terms of time and energy consumption.
Microwave synthesis has been important in the medicinal
chemistry which is useful for the rapid synthesis of a library
of large number of compounds.
Chalcones act as precursor for biologically important hetero-
cyclic compounds. It can be prepared by easy synthetic ap-
proaches and can be readily cyclized to a variety of compounds
including 2-pyrazolines. 2-Pyrazolines are biologically active
scaffolds with a variety of biological activities like antimicrobial
(Patel et al., 2012), antitubercular (Taj et al., 2011), anti-inﬂam-
matory (Bano et al., 2011), anticancer (Lee et al., 2011), antitu-
mor (Bai et al., 2012), anticonvulsant (Aboul-Enein et al.,
2012), and anti-HIV (Ali et al., 2007). 2-Pyrazolines have been
Fig. 1 2-Pyrazolines 2a–j.
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heating (Sridhar and Rajendraprasad, 2012; Koduru et al.,
2012; Santos et al., 2012) as well as from microwave irradiation
(Chawla et al., 2010; Azarifar and Ghasemnejad, 2003).
In this regard, we have also reported the cyclization of chal-
cones from conventional methods (Patel and Patel, 2010,
2012). Considering the above facts, here in this study, we are
reporting the synthesis of 2-pyrazolines from chalcones by con-
ventional and microwave techniques and a study of their com-
parison in terms of reaction time and yield as well as
antimicrobial activity.
2. Experimental
2.1. General
Laboratory Chemicals were supplied by Rankem India Ltd.
and Ficher Scientiﬁc Ltd. Melting points were determined by
the open tube capillary method and are uncorrected. IR
absorption spectra were recorded on a Thermo scientiﬁc Nico-
let iS10 FT-IR spectrometer using KBr pellet, 1H NMR spec-
tra were recorded in a CDCl3/DMSO-d6 Bruker Avance II 400
NMR (400 MHz FT NMR) instrument (chemical shifts in
d ppm), 13C NMR spectra were recorded in a Bruker Avance
II 400 NMR (100 MHz FT NMR) instrument (chemical shifts
in d ppm) and Mass spectra recorded on a micromass Q-T of
micro (TOF MS ES+). Elemental analyses were performed
on a Heraeus Carlo Erba 1180 CHN analyzer. The purity of
products was routinely checked by TLC using silica gel in tol-
uene:methanol solvents. The microwave assisted reactions
were conducted in a ‘‘QPro-M Microwave Synthesis System’’
manufactured by Questron Technologies Corporation, Ontar-
io L4Z 2E9 Canada, whereby microwaves are generated by
magnetron at a frequency of 2450 MHz having an output en-
ergy range of 100–500 Wand with an individual sensor for tem-
perature control (ﬁber optic is used as a individual sensor for
temperature control) with attachment of reﬂux condenser with
constant stirring (thus avoiding the risk of high pressure devel-
opment) and synthesis on preparative scales.
3-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)phenyl)-1-phenylprop-
2-en-1-ones 1a–j have been synthesized from reported methods
(Patel and Patel, 2009).
2.2. Synthesis of 5-Ethyl-2-{2-[4-(3-phenyl-4,5-dihydro-1H-
pyrazol-5-yl)phenoxy]ethyl} pyridine(2a)
Conventional method:
A mixture of 3-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)phenyl)-1-
phenylprop-2-en-1-ones 1a–j (0.003 mol) and hydrazine hy-
drate (0.0045 mol) was reﬂuxed for 5–6 h in acetic acid
(50 mL). Progress of the reaction was checked by TLC using
toluene:methanol (7.5:2.5) as mobile phase. After completion
of reaction, the mixture was cooled and poured into crushed
ice with continuous stirring. The resulting solid thus obtained
was collected by ﬁltration, washed well with cold water, dried
and recrystallized from methanol.
Microwave method:
A mixture of 3-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)phenyl)-
1-phenylprop-2-en-1-ones 1a–j (0.003 mol) and hydrazine
hydrate (0.0045 mol) was irradiated under microwave in sol-
vent-free conditions. All these reactions were carried out bymicrowave irradiation for 3–7 min at the power level 700 W
and at the temperature of 80–85 C which was recorded by
the temperature probe of the microwave. Progress of the reac-
tion was checked after a regular interval of one minute till the
completion of reaction by TLC using toluene:methanol
(7.5:2.5) as mobile. Product was collected by the same way
as in conventional methods.
Compounds 2(b–j) have also been synthesized by using the
similar method. (Fig. 1)
2.2.1. 5-Ethyl-2-{2-[4-(3-phenyl-4,5-dihydro-1H-pyrazol-5-
yl)phenoxy]ethyl}pyridine (2a)
m.p. 127–129 C; IR spectrum (cm1): 3268 (N–H), 2923, 2815
(C–H, asym, sym), 1617 (>C‚N), 1220, 1034 (C–O–C). 1H
NMR spectrum (400 MHz, CDCl3, TMS), d: 1.13 (t, 3H,
–CH3), 2.54 (q, 2H, –CH2–), 3.17 (t, 2H, –CH2–), 3.29–3.34
(dd, 1H, pyrazoline), 3.65–3.72 (dd, 1H, pyrazoline), 4.33 (t,
2H, –CH2–O), 5.87–5.91 (dd, 1H, pyrazoline), 6.98–7.70 (m,
9H, Ar–H), 8.23 (s, 1H, –NH), 7.18–8.32 (m, 3H, Pyridine-
H). 13C NMR spectrum (100 MHz, CDCl3, TMS), d: 18.72
(C-1), 25.90 (C-2), 35.61 (C-8), 46.76 (C-17), 55.20 (C-16),
69.20 (C-9), 114.80 (C-11,15), 123.92 (C-6), 125.61 (C-12,14),
127.93 (C-20,24), 128.71 (C-21,23), 131.97 (C-22), 134.71 (C-
7), 135.94 (C-3), 136.73 (C-13), 137.86 (C-19), 148.22 (C-4),
153.40 (C-18), 159.23 (C-5), 161.28 (C-10). MS: m/z 371.18
(M+). Elemental analyses data of C24H25N3O: calculated,
%: C, 77.60; H, 6.68; N, 11.31; found, %: C, 77.62; H, 6.66;
N, 11.29.
2.2.2. 5-Ethyl-2-{2-[4-(3-(4-methoxyphenyl)-4,5-dihydro-1H-
pyrazol-5-yl)phenoxy]ethyl} pyridine (2b)
m.p. 133–135 C; IR spectrum (cm1): 3273 (N–H), 2927, 2832
(C–H, asym, sym), 1624 (>C‚N), 1218, 1041 (C–O–C). 1H
NMR spectrum (400 MHz, CDCl3, TMS), d: 1.15 (t, 3H, –
CH3), 2.57 (q, 2H, –CH2–), 3.12 (t, 2H, –CH2–), 3.27–3.31
(dd, 1H, pyrazoline), 3.67–3.74 (dd, 1H, pyrazoline), 3.80 (s,
3H, –OCH3), 4.37 (t, 2H, –CH2–O), 5.89–5.93 (dd, 1H, pyraz-
oline), 7.16–8.27 (m, 3H, Pyridine-H), 7.05–7.82 (m, 8H, Ar–
H), 8.21 (s, 1H, –NH). 13C NMR spectrum (100 MHz, CDCl3,
TMS), d: 18.68 (C-1), 25.79 (C-2), 35.56 (C-8), 46.71 (C-17),
52.55 (-OCH3), 55.23 (C-16), 69.23 (C-9), 114.83 (C-11,15),
115.72 (C-21,23), 123.92 (C-6), 125.67 (C-12,14), 128.12
(C-20,24), 129.76 (C-19), 134.76 (C-7), 135.82 (C-3), 136.65
(C-13), 147.25 (C-4), 153.42 (C-18), 159.18 (C-5), 161.18 (C-
10), 164.93 (C-22). MS: m/z 401.15 (M+). Elemental analyses
data of C25H27N3O2; calculated, %: C, 74.79; H, 6.78; N,
10.47; found, %: C, 74.77; H, 6.75; N, 10.45.
2.2.3. 5-Ethyl-2-{2-[4-(3-(4-ﬂuorophenyl)-4,5-dihydro-1H-
pyrazol-5-yl)phenoxy]ethyl} pyridine (2c)
m.p. 112–114 C; IR spectrum (cm1): 3265 (N–H), 2930, 2835
(C–H, asym, sym), 1618 (>C‚N), 1221, 1035 (C–O–C), 1212
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(t, 3H, –CH3), 2.54 (q, 2H, –CH2–), 3.10 (t, 2H, –CH2–),
3.25–3.29 (dd, 1H, pyrazoline), 3.69–3.76 (dd, 1H, pyrazoline),
4.35 (t, 2H, –CH2–O), 5.87–5.91 (dd, 1H, pyrazoline), 7.05–
7.79 (m, 8H, Ar–H), 7.19–8.31 (m, 3H, Pyridine-H), 8.27 (s,
1H, –NH). 13C NMR spectrum (100 MHz, CDCl3, TMS), d:
18.68 (C-1), 25.79 (C-2), 35.56 (C-8), 46.71 (C-17), 55.23 (C-
16), 69.23 (C-9), 114.83 (C-11,15), 116.43 (C-21,23), 123.92
(C-6), 125.67 (C-12,14), 130.32 (C-20,24), 132.16 (C-19),
134.76 (C-7), 135.82 (C-3), 136.65 (C-13), 147.25 (C-4),
153.42 (C-18), 159.18 (C-5), 161.18 (C-10), 167.91 (C-22).
MS: m/z 389.19 (M+). Elemental analyses data of
C24H24FN3O: calculated, %: C, 74.01; H, 6.21; N, 10.79;
found, %: C, 74.03; H, 6.19; N, 10.81.
2.2.4. 5-Ethyl-2-{2-[4-(3-(2,4-dichlorophenyl)-4,5-dihydro-1H-
pyrazol-5-yl)phenoxy]ethyl} pyridine (2d)
m.p. 145–147 C; IR spectrum (cm1): 3264 (N–H), 2927, 2836
(C–H, asym, sym), 1621 (>C‚N), 1215, 1030 (C–O–C), 760
(C–Cl). 1H NMR spectrum (400 MHz, CDCl3, TMS), d: 1.12
(t, 3H, –CH3), 2.57 (q, 2H, –CH2–), 3.12 (t, 2H, –CH2–),
3.29–3.33 (dd, 1H, pyrazoline), 3.61–3.70 (dd, 1H, pyrazoline),
4.31 (t, 2H, –CH2–O), 5.82–5.87 (dd, 1H, pyrazoline), 7.00–
7.76 (m, 7H, Ar–H), 7.21–8.21 (m, 3H, Pyridine-H), 8.29 (s,
1H, –NH). 13C NMR spectrum (100 MHz, CDCl3, TMS), d:
18.62 (C-1), 25.76 (C-2), 35.45 (C-8), 46.69 (C-17), 55.22 (C-
16), 69.24 (C-9), 114.72 (C-11,15), 123.88 (C-6), 125.58 (C-
12,14), 126.68 (C-20), 128.91 (C-21), 131.98 (C-22), 133.35
(C-23), 134.71 (C-7), 135.18 (C-24), 135.76 (C-3), 136.62 (C-
13), 137.74 (C-19), 147.21 (C-4), 153.34 (C-18), 159.11 (C-5),
161.10 (C-10). MS: m/z 439.12 (M+), 441.15 (M++2),
443.17 (M++4). Elemental analyses data of C24H23Cl2N3O:
calculated, %: C, 65.46; H, 5.26; N, 9.54; found, %: C,
65.44; H, 5.28; N, 9.56.
2.2.5. 5-Ethyl-2-{2-[4-(3-(4-hydroxyphenyl)-4,5-dihydro-1H-
pyrazol-5-yl)phenoxy]ethyl} pyridine (2e)
m.p. 137–139 C; IR spectrum (cm1): 3325 (O–H), 3261 (N–
H), 2921, 2841 (C–H, asym, sym), 1612 (>C‚N), 1204,
1018 (C–O–C). 1H NMR spectrum (400 MHz, CDCl3,
TMS), d: 1.12 (t, 3H, –CH3), 2.59 (q, 2H, –CH2–), 3.15 (t,
2H, –CH2–), 3.25–3.29 (dd, 1H, pyrazoline), 3.65–3.74 (dd,
1H, pyrazoline), 4.28 (t, 2H, –CH2–O), 5.76–5.81 (dd, 1H, pyr-
azoline), 7.04–7.69 (m, 8H, Ar–H), 7.15–8.24 (m, 3H, Pyridine-
H), 8.71 (s, 1H, –NH), 9.01 (s, 1H, –OH). 13C NMR spectrum
(100 MHz, CDCl3, TMS), d: 18.58 (C-1), 25.71 (C-2), 35.43 (C-
8), 46.62 (C-17), 55.18 (C-16), 69.21 (C-9), 114.65 (C-11,15),
118.65 (C-21,23), 123.82 (C-6), 125.48 (C-12,14), 128.65 (C-
19), 129.62 (C-20,24), 134.65 (C-7), 135.71 (C-3), 136.68 (C-
13), 147.12 (C-4), 153.38 (C-18), 159.21 (C-5), 161.28 (C-10),
163.85 (C-22). MS: m/z 387.19 (M+). Elemental analyses data
of C24H25N3O2: calculated, %: C, 74.39; H, 6.50; N, 10.84;
found, %: C, 74.36; H, 6.47; N, 10.83.
2.2.6. 5-Ethyl-2-{2-[4-(3-(3,4-dichlorophenyl)-4,5-dihydro-1H-
pyrazol-5-yl)phenoxy]ethyl} pyridine (2f)
m.p. 156–158 C; IR spectrum (cm1): 3272 (N–H), 2928, 2832
(C–H, asym, sym), 1622 (>C‚N), 1212, 1021 (C–O–C), 765
(C–Cl). 1H NMR spectrum (400 MHz, CDCl3, TMS), d: 1.11
(t, 3H, –CH3), 2.61 (q, 2H, –CH2–), 3.12 (t, 2H, –CH2–),
3.27–3.31 (dd, 1H, pyrazoline), 3.61–3.70 (dd, 1H, pyrazoline),4.31 (t, 2H, –CH2–O), 5.78–5.83 (dd, 1H, pyrazoline), 6.96–
7.71 (m, 7H, Ar–H), 7.18–8.25 (m, 3H, Pyridine-H), 8.67 (s,
1H, –NH). 13C NMR spectrum (100 MHz, CDCl3, TMS), d:
18.62 (C-1), 25.65 (C-2), 35.53 (C-8), 46.61 (C-17), 55.23
(C-16), 69.25 (C-9), 114.69 (C-11,15), 123.85 (C-6), 125.52
(C-12,14), 126.18 (C-24), 130.63 (C-20), 130.85 (C-23), 132.92
(C-21), 133.71 (C-19), 134.58 (C-7), 135.67 (C-3), 136.12 (C-
22), 136.78 (C-13), 147.18 (C-4), 153.45 (C-18), 159.31 (C-5),
161.29 (C-10). MS: m/z 439.15 (M+), 441.17 (M++2),
444.16 (M++4). Elemental analyses data of C24H23Cl2N3O:
calculated, %: C, 65.46; H, 5.26; N, 9.54; found, %: C,
65.48; H, 5.26; N, 9.52.
2.2.7. 5-Ethyl-2-{2-[4-(3-(3-methoxyphenyl)-4,5-dihydro-1H-
pyrazol-5-yl) phenoxy]ethyl} pyridine (2g)
m.p. 161–163 C; IR spectrum (cm1): 3262 (N–H), 2927, 2821
(C–H, asym, sym), 1618 (>C‚N), 1212, 1028 (C–O–C). 1H
NMR spectrum (400 MHz, CDCl3, TMS), d: 1.18 (t, 3H,
–CH3), 2.58 (q, 2H, –CH2–), 3.18 (t, 2H, –CH2–), 3.26–3.30
(dd, 1H, pyrazoline), 3.63–3.73 (dd, 1H, pyrazoline), 3.82 (s,
3H, –OCH3), 4.26 (t, 2H, –CH2–O), 5.76–5.81 (dd, 1H, pyraz-
oline), 7.04–7.72 (m, 8H, Ar–H), 7.12–8.29 (m, 3H, Pyridine-
H), 8.56 (s, 1H, –NH). 13C NMR spectrum (100 MHz, CDCl3,
TMS), d: 18.67 (C-1), 25.69 (C-2), 35.51 (C-8), 46.58 (C-17),
55.21 (C-16), 69.28 (C-9), 112.59 (C-20), 114.62 (C-11,15),
116.78 (C-22), 120.59 (C-24), 123.81 (C-6), 125.48 (C-12,14),
130.17 (C-23), 134.51 (C-7), 135.62 (C-3), 136.71
(C-13), 137.79 (C-19), 147.25 (C-4), 153.48 (C-18), 159.21 (C-
5), 161.35 (C-10), 162.86 (C-21). MS: m/z 401.17 (M+). Ele-
mental analyses data of C25H27N3O2: calculated, %: C,
74.79; H, 6.78; N, 10.47; found, %: C, 74.75; H, 6.81; N, 10.50.
2.2.8. 5-Ethyl-2-{2-[4-(3-(3-ﬂuorophenyl)-4,5-dihydro-1H-
pyrazol-5-yl)phenoxy]ethyl} pyridine (2h)
m.p. 168–169 C; IR spectrum (cm1): 3238 (N–H), 2931, 2829
(C–H, asym, sym), 1618 (>C‚N), 1212, 1022 (C–O–C), 1225
(C–F). 1H NMR spectrum (400 MHz, CDCl3, TMS), d: 1.11
(t, 3H, –CH3), 2.61 (q, 2H, –CH2–), 3.23 (t, 2H, –CH2–),
3.22–3.26 (dd, 1H, pyrazoline), 3.68–3.77 (dd, 1H, pyrazoline),
4.31 (t, 2H, –CH2–O), 5.72–5.77 (dd, 1H, pyrazoline), 7.02–
7.65 (m, 8H, Ar–H), 7.08–8.30 (m, 3H, Pyridine-H), 8.51 (s,
1H, –NH). 13C NMR spectrum (100 MHz, CDCl3, TMS), d:
18.57 (C-1), 25.64 (C-2), 35.45 (C-8), 46.52 (C-17), 55.27
(C-16), 69.21 (C-9), 113.56 (C-20), 114.68 (C-11,15), 117.72
(C-22), 123.78 (C-6), 124.12 (C-24), 125.42 (C-12,14), 129.92
(C-23), 134.45 (C-7), 135.58 (C-3), 136.67 (C-13), 137.74 (C-
19), 147.21 (C-4), 153.43 (C-18), 159.17 (C-5), 161.28 (C-10),
163.69 (C-21). MS: m/z 389.15 (M+). Elemental analyses data
of C24H24FN3O: calculated, %: C, 74.01; H, 6.21; N, 10.79;
found, %: C, 74.05; H, 6.24; N, 10.76.
2.2.9. 5-Ethyl-2-{2-[4-(3-(4-chlorophenyl)-4,5-dihydro-1H-
pyrazol-5-yl)phenoxy]ethyl} pyridine (2i)
m.p. 118–119 C; IR spectrum (cm1): 3242 (N–H), 2928, 2834
(C–H, asym, sym), 1612 (>C‚N), 1202, 1018 (C–O–C), 766
(C–Cl). 1H NMR spectrum (400 MHz, CDCl3, TMS), d: 1.15
(t, 3H, –CH3), 2.57 (q, 2H, –CH2–), 3.27 (t, 2H, –CH2–),
3.21–3.25 (dd, 1H, pyrazoline), 3.70–3.78 (dd, 1H, pyrazoline),
4.25 (t, 2H, –CH2–O), 5.68–5.73 (dd, 1H, pyrazoline), 6.94–
7.64 (m, 8H, Ar–H), 7.12–8.20 (m, 3H, Pyridine-H), 8.49 (s,
1H, –NH). 13C NMR spectrum (100 MHz, CDCl3, TMS), d:
2 2 2
Scheme 1 Synthesis of 2-pyrazolines from chalcones via con-
ventional and microwave irradiated techniques.
S454 N.B. Patel et al.18.62 (C-1), 25.61 (C-2), 35.42 (C-8), 46.48 (C-17), 55.31
(C-16), 69.27 (C-9), 114.65 (C-11,15), 123.74 (C-6), 125.35
(C-12,14), 127.45 (C-20,24), 128.61 (C-21,23), 134.32 (C-7),
135.48 (C-3), 136.57 (C-13), 137.72 (C-19), 138.65 (C-22),
147.18 (C-4), 153.46 (C-18), 159.21 (C-5), 161.31 (C-10). MS:
m/z 405.16 (M+), 407.18 (M++2). Elemental analyses data
of C24H24ClN3O: calculated, %: C, 71.01; H, 5.96; N, 10.35;
found, %: C, 71.03; H, 5.94; N, 10.37.
2.2.10. 5-Ethyl-2-{2-[4-(3-(2,4-diﬂuorophenyl)-4,5-dihydro-
1H-pyrazol-5-yl)phenoxy] ethyl} pyridine (2j)
m.p. 149–151 C; IR spectrum (cm1): 3232 (N–H), 2912, 2831
(C–H, asym, sym), 1622 (>C‚N), 1201, 1023 (C–O–C), 1212
(C–F). 1H NMR spectrum (400 MHz, CDCl3, TMS), d: 1.18
(t, 3H, –CH3), 2.48 (q, 2H, –CH2–), 3.29 (t, 2H, –CH2–),
3.23–3.27 (dd, 1H, pyrazoline), 3.67–3.75 (dd, 1H, pyrazoline),
4.28 (t, 2H, –CH2–O), 5.66–5.71 (dd, 1H, pyrazoline), 6.98–
7.79 (m, 7H, Ar–H), 7.10–8.20 (m, 3H, Pyridine-H), 8.32 (s,
1H, –NH). 13C NMR spectrum (100 MHz, CDCl3, TMS), d:
18.54 (C-1), 25.52 (C-2), 35.37 (C-8), 46.41 (C-17), 55.28 (C-
16), 69.25 (C-9), 111.51 (C-23), 112.68 (C-21), 113.68 (C-19),Table 1 Comparison of conventional and microwave techniques.
Comp. No. R Irradiation in Microwa
Time (min)
2a -H 4.2
2b 4-OCH3 4.8
2c 4-F 6.5
2d 2,4-di-Cl 6.2
2e 4-OH 3.8
2f 3,4-di-Cl 4.5
2g 3-OCH3 5.6
2h 3-F 4.0
2i 4-Cl 5.2
2j 2,4-di-F 5.7114.71 (C-11,15), 123.72 (C-6), 125.21 (C-12,14), 132.34 (C-
24), 134.26 (C-7), 135.38 (C-3), 136.47 (C-13), 147.21 (C-4),
153.36 (C-18), 159.11 (C-5), 161.23 (C-10), 162.34 (C-20),
165.15 (C-22), MS: m/z 407.18 (M+). Elemental analyses data
of C24H23F2N3O: calculated, %: C, 70.75; H, 5.69; N, 10.31;
found, %: C, 70.73; H, 5.71; N, 10.33.
3. Result and discussion
3.1. Chemistry
Cyclization of chalcone with hydrazine hydrate in conven-
tional and microwave methods has been described in Scheme 1.
Comparison of conventional and microwave techniques, in
terms of time and yields has been described in Table 1. Spectral
and elemental analyses data conformed the structure of com-
pounds 2a–j. In IR spectra an absorption band at 3232 cm1
was observed for N–H stretching. Absorption band at 2928,
2812 cm1 was observed for the methylene group. Absorption
bands for functional groups like 1552, 1330 cm1 (–NO2 asym,
sym), 1220 cm1 (C–F), 1215, 1028 cm1 (C–O–C), 767 cm1
(C–Cl) were observed. In 1H NMR spectra of 2a–j three dou-
ble doublets observed at d 3.23–3.27, 3.67–3.75 and 5.66–5.71
conformed the cyclization of chalcones to 2-pyrazolines. Sing-
lets at d 3.78 for methoxy and 9.1 for hydroxy group were also
observed. 13C NMR spectra for compounds 2a–j were in
accordance with expected shifts. Mass spectra of compounds
2a–j were collected and the molecular ion peak was found cor-
rect according to the molecular formula.
3.2. Antibacterial and antifungal activities
Antimicrobial activity of synthesized compounds is reported in
Table 2. Compounds were screened for in vitro against two
Gram positive (Staphylococcus aureusMTCC 96, Streptococcus
pyogenesMTCC 442) and two Gram negative (Escherichia coli
MTCC 443, Pseudomonas aeruginosa MTCC 741) bacteria for
antibacterial and three fungal species (Candida albicansMTCC
227, Aspergillus niger MTCC 282 and Aspergillus clavatus
MTCC 1323) for antifungal activity respectively using the
broth microdilution method (Rattan, 2005). Minimum inhibi-
tory concentration (MIC) was determined and compared with
standard drugs ampicillin for antibacterial activity while gre-
seofulvin and nystatin for antifungal activity.
Compounds 2b (R = 4-OCH3), 2d (R = 2,4-di-Cl) and 2j
(R = 2,4-di-F) showed good to comparable activityve Conventional Reﬂuxed
Yield % Time (hour) Yield %
87 4.4 76
84 3.8 78
89 5.1 75
86 5.8 72
85 5.2 79
84 4.6 73
83 4.9 74
82 4.2 76
89 5.1 73
85 5.5 76
Table 2 Antimicrobial data of compounds 2a–j.
Compd. No. R Minimum Inhibition Concentration in lg/ml
Gram negative Gram negative Fungal species
E. coli P. aeruginosa S. aureus S. pyogenes C. albicans A. niger A. clavatus
2a -H 500 500 200 200 >1000 >1000 >1000
2b 4-OCH3 100 200 250 250 >1000 200 200
2c 4-F 200 200 500 500 >1000 500 500
2d 2,4-di-Cl 100 62.5 500 500 250 1000 1000
2e 4-OH 200 100 250 250 500 1000 1000
2f 3,4-di-Cl 200 200 250 250 100 500 500
2g 3-OCH3 250 250 500 500 250 500 500
2h 3-F 250 250 200 200 200 500 500
2i 4-Cl 200 200 200 200 500 500 500
2j 2,4-di-F 125 250 100 100 500 1000 1000
Ampicillin 100 100 250 100 – – –
Griseofulvin – – – 500 100 100
Nystatin – – – 100 100 100
Synthesis of 2-pyrazolines from pyridine based chalcone by conventional and microwave techniques: S455(MIC = 100–125 lg/ml) whereas 2c (R = 4-F), 2e (R =
4-OH), 2f (R = 3,4-di-Cl) and 2i (R = 4-Cl) showed a moder-
ate activity (MIC = 200 lg/ml) against E. coli. Compounds 2d
(R = 2,4-di-Cl) and 2e (R = 4-OH) exhibited good activity
(MIC = 62.5–100 lg/ml) whereas 2b (R = 4-OCH3), 2c
(R = 4-F), 2f (R = 3,4-di-Cl) and 2i (R = 4-Cl) showed a
moderate activity (MIC = 200 lg/ml) against P. aeruginosa.
Compounds 2a (R = -H), 2b (R = 4-OCH3), 2e (R = 4-
OH), 2f (R = 3,4-di-Cl), 2h (R = 3-F), 2i (R = 4-Cl) and 2j
(R = 2,4-di-F) showed good to very good activity
(MIC = 100–250 lg/ml) against S. aureus. None of the com-
pounds except 2j (R = 2,4-di-F) showed good activity
(MIC = 100 lg/ml) against S. pyogenes.
Compounds 2d (R = 2,4-di-Cl), 2e (4-OH), 2f (R = 3,4-di-
Cl), 2g (3-OCH3), 2h (R = 3-F), 2i (R = 4-Cl) and 2j
(R = 2,4-di-F) displayed very good to good activity
(MIC = 100–500 lg/ml) against C. albicans, when compared
with standard drug griseofulvin. Compound 2f (3,4-di-Cl)
showed good to comparable activity (MIC = 100–125 lg/ml)
against C. albicans when compared with nystatin. None of
the synthesized compounds showed good activity against other
two fungal species A. niger and A. clavatus.
4. Conclusion
A series of 2-pyrazolines have been synthesized from cycliza-
tion of chalcones by a conventional heating approach as well
as non-conventional microwave irradiated solvent free
conditions and evaluated as antibacterial and antifungal
agents. Most of the compounds were found active against S.
aureus as antibacterial while against C. albicans as antifungal
agents. The non-conventional protocol offers several advanta-
ges such as simple procedure, fast reaction rate, mild reaction
conditions and improved yields compared to conventional
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